XBP1 and cancer: Consistent with the immunogenic effects induced upon deleting or silencing Xbp1 in tDCs, targeting lipid uptake or inhibiting key mediators of fatty acid oxidation has been shown to boost anti-cancer immunity by enhancing myeloid cell function in the tumor microenvironment [82–84].